FANCM is required for the PAX3::FOXO1-driven oncogenic program in rhabdomyosarcoma. (linkinghub.elsevier.com)

Authors: Delaney CD … Wood KC Journal: Cell Reports Published: 2026-09-08 DOI: https://doi.org/10.1016/j.celrep.2026.117960